Taken together, the results show that inhibition of the MEK/ERK pathway improves insulin resistance not only by down‐regulating PPARγ phosphorylation, but also through PPARγ‐independent reduction of inflammatory cytokine secretion by adipocytes and monocytes. Here, PPARG is linked to Insulin resistance.